Literature DB >> 17266070

Health values of patients with systemic sclerosis.

Dinesh Khanna1, Mansoor Ahmed, Daniel E Furst, Shaari S Ginsburg, Grace S Park, Richard Hornung, Joel Tsevat.   

Abstract

OBJECTIVE: To assess health values in subjects with systemic sclerosis (SSc) and determine variability explained by demographics, clinical factors, health status, and disease severity.
METHODS: We interviewed 107 individuals with SSc who attended national and local Scleroderma Foundation meetings in 2005. Health status was measured using the Short Form 36 (SF-36) Physical Component Summary (PCS; range 0-100) and Mental Component Summary (MCS; range 0-100), the Center for Epidemiologic Studies Depression Scale (CES-D; range 0-60), and the Health Assessment Questionnaire (HAQ) disability index (DI; range 0-3). Disease severity was assessed using a visual analog scale (VAS; range 0-150). Health value measures included the 0-100 health rating scale (RS), standard gamble (SG; range 0.0-1.0), and time trade-off (TTO; range 0.0-1.0). We performed univariate analyses to compare scores between participants with limited cutaneous SSc (lcSSc) and diffuse cutaneous SSc (dcSSc), and multivariable analyses for 3 outcome measures: RS, SG, and TTO, controlling for demographics, type of SSc, health status, and disease severity.
RESULTS: Of the 107 participants, 48 had dcSSc and 59 had lcSSc. Ninety-seven were women and 83 were white. The median scores for the PCS, MCS, and HAQ DI were 36.9, 45.5, and 0.9, respectively. Fifty-five subjects had significant depressive symptoms (CES-D score >or=16). The median RS, SG, and TTO scores were 62, 0.83 (indicating a willingness to accept up to a 17% risk of immediate death in exchange for perfect health), and 0.88 (indicating a willingness to give up a median of 12% of life expectancy in exchange for perfect health), respectively. Subjects with dcSSc had lower RS scores but higher SG scores (corresponding to a willingness to accept only a smaller risk of death) than subjects with lcSSc. TTO scores were similar in the 2 groups. Health values were variably related to factors such as demographics, VAS score, disease classification, and SF-36 PCS and MCS scores (R(2) = 0.22, 0.23, and 0.66 for the SG, TTO, and RS models, respectively).
CONCLUSION: Individuals with dcSSc have lower health ratings but higher SG health values than individuals with lcSSc. These findings have implications for decision analysis and cost-effectiveness analysis.

Entities:  

Mesh:

Year:  2007        PMID: 17266070     DOI: 10.1002/art.22465

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

1.  Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.

Authors:  Roozbeh Sharif; Maureen D Mayes; Perry M Nicassio; Emilio B Gonzalez; Hilda Draeger; Terry A McNearney; Rosa M Estrada-Y-Martin; Deepthi K Nair; John D Reveille; Frank C Arnett; Shervin Assassi
Journal:  Semin Arthritis Rheum       Date:  2011-03-22       Impact factor: 5.532

2.  Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.

Authors:  Dinesh Khanna; Daniel E Furst; Weng Kee Wong; Joel Tsevat; Philip J Clements; Grace S Park; Arnold E Postlethwaite; Mansoor Ahmed; Shaari Ginsburg; Ron D Hays
Journal:  Qual Life Res       Date:  2007-04-03       Impact factor: 4.147

3.  Development of a provisional core set of response measures for clinical trials of systemic sclerosis.

Authors:  D Khanna; D J Lovell; E Giannini; P J Clements; P A Merkel; J R Seibold; M Matucci-Cerinic; C P Denton; M D Mayes; V D Steen; J Varga; D E Furst
Journal:  Ann Rheum Dis       Date:  2007-09-24       Impact factor: 19.103

4.  Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?

Authors:  Adam J N Raymakers; Nicole W Tsao; Carlo A Marra; Philip J Clements; Dinesh Khanna
Journal:  J Rheumatol       Date:  2016-08-01       Impact factor: 4.666

5.  Risk factors for body composition abnormalities in systemic sclerosis.

Authors:  Thais F Marighela; Patrícia de S Genaro; Marcelo M Pinheiro; Vera L Szejnfeld; Cristiane Kayser
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

Review 6.  Negative affect in systemic sclerosis.

Authors:  Leticia Leon; Lydia Abasolo; Marta Redondo; Miguel Angel Perez-Nieto; Luis Rodriguez-Rodriguez; Maria Isabel Casado; Rafael Curbelo; Juan Angel Jover
Journal:  Rheumatol Int       Date:  2013-09-27       Impact factor: 2.631

7.  Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis.

Authors:  Vijay Bodukam; Ron D Hays; Paul Maranian; Daniel E Furst; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2010-09-30       Impact factor: 7.580

Review 8.  A systematic comparison of fatigue levels in systemic sclerosis with general population, cancer and rheumatic disease samples.

Authors:  B D Thombs; M Bassel; L McGuire; M T Smith; M Hudson; J A Haythornthwaite
Journal:  Rheumatology (Oxford)       Date:  2008-08-13       Impact factor: 7.580

9.  An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility.

Authors:  Chiara M Antonioli; Giovanni Bua; Anna Frigè; Katia Prandini; Sara Radici; Mirko Scarsi; Elisabetta Danieli; Andrea Malvicini; Paolo Airo
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

10.  Social/economic costs and health-related quality of life in patients with scleroderma in Europe.

Authors:  Julio López-Bastida; Renata Linertová; Juan Oliva-Moreno; Pedro Serrano-Aguilar; Manuel Posada-de-la-Paz; Panos Kanavos; Domenica Taruscio; Arrigo Schieppati; Georgi Iskrov; Márta Péntek; Claudia Delgado; Johann Mathias von der Schulenburg; Ulf Persson; Karine Chevreul; Giovanni Fattore
Journal:  Eur J Health Econ       Date:  2016-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.